Unknown

Dataset Information

0

The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells.


ABSTRACT: A gold standard of antiviral vaccination has been the safe and effective live-attenuated 17D-based yellow fever virus (YFV) vaccines. Among more than 500 million vaccinees, only a handful of cases have been reported in which vaccinees developed a virulent wild type YFV infection. This efficacy is presumed to be the result of both neutralizing antibodies and a robust T cell response. However, the particular immune components required for protection against YFV have never been evaluated. An understanding of the immune mechanisms that underlie 17D-based vaccine efficacy is critical to the development of next-generation vaccines against flaviviruses and other pathogens. Here we have addressed this question for the first time using a murine model of disease. Similar to humans, vaccination elicited long-term protection against challenge, characterized by high neutralizing antibody titers and a robust T cell response that formed long-lived memory. Both CD4+ and CD8+ T cells were polyfunctional and cytolytic. Adoptive transfer of immune sera or CD4+ T cells provided partial protection against YFV, but complete protection was achieved by transfer of both immune sera and CD4+ T cells. Thus, robust CD4+ T cell activity may be a critical contributor to protective immunity elicited by highly effective live attenuated vaccines.

SUBMITTER: Watson AM 

PROVIDER: S-EPMC4962991 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3883177 | biostudies-literature
| S-EPMC4071376 | biostudies-literature
| S-EPMC5780476 | biostudies-literature
| S-EPMC4792480 | biostudies-literature
2008-12-01 | GSE13699 | GEO
| S-EPMC3323739 | biostudies-literature
2017-06-25 | GSE82152 | GEO
| S-EPMC4896586 | biostudies-other
| S-EPMC10640814 | biostudies-literature
| S-EPMC7564786 | biostudies-literature